On Oct. 2, 2020, the World Health Organization (WHO) and the Kingdom of Saudi Arabia signed a contribution…
On Oct. 2, 2020, Quidel announced that it had received Emergency Use Authorization from the U.S. Food and…
On Oct. 2, 2020, the Uconn Office of the Vice President for Research (OVPR) announced a new internal…
On Oct. 2, 2020, LabCorp announced that it had received an Emergency Use Authorization (EUA) from the U.S….
On Oct. 1, 2020, widespread accurate testing for SARS-CoV-2, the virus that causes COVID-19, is one critical aspect…
On Oct. 1, 2020, Gilead Sciences announced that it will be responsible for distributing Veklury in the U.S….
On Oct. 1, 2020, Amyris announced that it has begun delivering samples to pharmaceutical companies of a sustainable…
On Oct. 1, 2020, Johnson & Johnson announced it had successfully completed its acquisition of Momenta Pharmaceuticals, a…
On Sept. 30, 2020, researchers at the Karolinska Institutet in Sweden and the Max Planck Institute for Evolutionary…
On Sept. 30, 2020, the National Institutes of Health (NIH) announced that it had awarded nearly $234 million…
On Sept. 30, 2020, University of Oxford researchers announced they had begun a new study to explore the…
On Sept. 30, 2020, the National Institutes of Health (NIH) announced funding of a nationwide study to discover…
On Sept. 30, 2020, the United Nations (UN) and its partners announced that nearly $1 billion in financing…
On Sept. 30, 2020, ViralClear Pharmaceuticals and Sorrento Therapeutics announced the companies were exploring the synergistic potential of…
On Sept. 30, 2020, Bio-Techne announced the opening of its approximately 61,000 square foot state-of-the-art GMP (Good Manufacturing…
On Sept. 30, 2020, Quest Diagnostics announced three different test options for healthcare providers across the U.S.to aid…
On Sept. 30, 2020, BD (Becton, Dickinson) announced its rapid, point-of-care, SARS-CoV-2 antigen test for use on the…
On Sept. 30, 2020, Pfizer and BioNTech announced that preliminary, peer-reviewed data from their ongoing German Phase 1/2…
On Sept. 30, 2020, researchers from the Perelman School of Medicine at the University of Pennsylvania reported results…
On Sept. 29, 2020, the National Institute of Allergy and Infectious Diseases (NIAID) announced that a phase 1…
On Sept. 29, 2020, the Centers for Disease Control and Prevention (CDC) reported that during Aug. 2-Sept. 5,…
On Sept. 29, 2020, the National Institutes of Health (NIH) announced that researchers had designed ”miniproteins’ that bound…
On Sept. 29, 2020, Oxford Immunotec announced that it had received clearance from the U.S. Food and Drug…
On Sept. 29, 2020, a further collaboration among the Serum Institute of India (SII), Gavi and the Bill…
On Sept. 29, 2020, In a new Letter, published in PNAS, researchers at La Jolla Institute for Immunology…
On Sept. 29, 2020, Moderna announced the publication of the second interim analysis of the open-label Phase 1…
On Sept. 29, 2020, Regeneron announced the first data from a descriptive analysis of a seamless Phase 1/2/3…
On Sept. 29, 2020, AXIM Biotechnologies announced that it has filed a provisional patent for a first-in-class face…
On Sept. 29, 2020, Windtree Therapeutics announced that U.S. Food and Drug Administration (FDA) has accepted its Investigational…
On Sept. 29, 2020, a phase 1 trial of an investigational mRNA vaccine to prevent SARS-CoV-2 infection was…